News

The STARLYNG-1 trial tested a weekly oral version of risperidone for schizophrenia, showing it maintains therapeutic drug levels and reduces side effects. The study found that the weekly pill may help improve medication adherence.

A series of digital tests, carried out via a smartphone app, could enhance the detection of disease progression in Huntington’s disease and improve the efficiency of clinical trials.

Researchers identified genetic variations in environmental sensitivity, explaining why individuals react differently to life experiences. The largest twin study of its kind, it found genetic markers related to mental health traits.

A new study making use of AI algorithms has shown that the brain's "reward center" operates in a much more sophisticated way than previously thought.

A study found that psilocybin improved multiple domains of psychological well-being in clergy. The study showed significant positive changes in religious attitudes and behaviors, effectiveness as a religious leader and non-religious attitudes.

A study from King’s College London links gut bacteria changes to cognitive decline in Parkinson’s disease. The research suggests that oral-gut translocation, where harmful bacteria move from the mouth to the gut, may contribute to symptoms.

A gut-derived compound called propionate may slow the progression of Alzheimer's disease by reducing inflammation and plaque build-up in the brain, new research in mice suggests.

The findings, published in Neurology, suggest that changes associated with ageing may occur earlier than previously recognized in this population.

A study from the University of Waterloo found that passionate hockey fans experience heightened brain activity, particularly in the dorsal medial prefrontal cortex, during key moments like offensive faceoffs.

A study involving over 2,800 teens found that poor sleep quality and duration are linked to reduced brain connectivity in areas related to decision-making, self-regulation and processing.